When the defendant does not pay the above fine, 100,000 won.

No one shall indicate or advertise that the name, raw materials, manufacturing methods, nutrients, ingredients, methods of use, quality, and traceability of functional health foods has efficacy or effect in preventing and treating diseases, or that such labeling or advertisement is likely to mislead or confuse as medicine with regard to the name of functional health foods.

Nevertheless, at around 12:00 on June 16, 2015, the Defendant posted a title “C” in the Defendant’s operation of Seongdong-gu Seoul Metropolitan Government B Cdong 3, providing that “I,” “I,” on the website following the Internet site, introduce DNA products “I,” and publish the PLAG’s efficacy as “I, I,” which is the main ingredient of D, “I, I, introduce Megos virine Products,” and “I, I, at the Internet site, introduce the PLG’s main ingredient. IL-6 effective control at the time of an operation, thereby preventing crymosis infection.” By regulating IL-4 products of Th1 and Th2, I would have the effect of preventing the cryp infection, preventing the cryp infection and the cryp infection, preventing the cryp infection from spreading, preventing the cryp infection’s infection and/or Th-I. 2, preventing the cryp infection.

Summary of Evidence

1. A protocol concerning the suspect examination of the accused;

1. Labeling that the effect, efficacy, or effect is likely to be mistaken for, or confused for, the prevention and treatment of a disease, and the application of advertising Acts and subordinate statutes;

1. Article 44 subparagraph 4 of the relevant Act and Articles 18 (1) 1 and 18 (1) 1 of the Health Functional Foods Act concerning criminal facts and the selection of fines;

1. Articles 70 (1) and 69 (2) of the Criminal Act for the detention of a workhouse;

1. Article 334 (1) of the Criminal Procedure Act of the provisional payment order;